The In Vivo blog provides another view on Valeant's hostile takeover bid for Cephalon. The post notes some of the ironies associated with the comments of Valeant's CEO Michael Pearson when he makes comments about Cephalon's asset valuation, risk profile, track record for recent acquisitions, etc.
Deals of the Week Is Not Ripe for Restructuring.
In order for Valeant to pull off this deal as proposed, it will increase its borrowing up to $11.2 B from its current $4.5 B and boost its leverage ratio to just over 4:1. Pretty brash stuff to be throwing stones.
Posted by Bruce Lehr April 2nd 2011.
Comments